Cite
HARVARD Citation
Hiremath, S. et al. (2023). Early Experience with Modified Dose Nirmatrelvir/Ritonavir in Dialysis Patients with Coronavirus Disease 2019. Clinical journal of the American Society of Nephrology. 18 (4), pp. 485-490. [Online].